Navigation Links
Hard To Treat Diseases (HTDS) Recapitalization
Date:1/9/2009

BELGRADE, Serbia, Jan. 9 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com the company having recently completed a merger with Slavica Bio Chem (Formerly ReNuYu Biochem) intends to recapitalize to 5 billion shares to pay for the Slavica merger and the pending China Bio Chem merger. Consideration for Slavica is 300 million non-dilatable restricted shares to be distributed amongst all doctors involved in Belgrade Serbia research. Key medical consultants and X ReNuYu management will receive stock options at a .03c strike price for up to 9% of the company common stock.

At present the company stock formulation details are as follows: Number of Common Shares Authorized: 1,200,000,000. Number of Common Shares Outstanding 862,581,959. Number of Restricted Shares: 480,091,291 Number of Preferred Shares Authorized: 25,000,000. Number of Preferred Shares Issued: None. The company intends to issue 10,000 convertible preferred shares to secure debt financing of about 1.5 million dollars.

The company's primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. Other interests include an on line cosmetics company.

The company will provide further details as they become available.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.

CONTACT: For scientific dialogue and any medical inquiry only please contact Andrea Rubio Zecevic via e-mail at

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Study Finds More Effective Treatment for Pneumonia Following Influenza
2. Study finds more effective treatment for pneumonia following influenza
3. Identification of genetic markers for ulcerative colitis could lead to treatment
4. Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder
5. Hard To Treat Diseases (HTDS) Set To Acquire Cosmetics Company
6. Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
7. Kawasaki Disease Treated with Plasma-Derived Therapy
8. Unnecessary Spinal Surgery Will Waste Billions of Dollars in 2009 and Patients Will Continue to Suffer Unless the Primary Cause of Most Back Pain is Treated, Says Pain Specialist Norman Marcus, M.D.
9. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
10. First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center
11. Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 LifeAnt.com, a life insurance ... a new article to its website that may cause ... a tad dismayed. Titled “Coffee Drinkers Beware! You’re Paying ... states on average, coffee fans tend to pay higher ... do not enjoy the tasty beverage. , In fact, ...
(Date:9/22/2014)... BOSTON -- In a collaboration that will encompass ... research and patient care and accelerate personalized genomic ... Deaconess Medical Center (BIDMC) have established a new ... announced today. , A recently signed agreement calls ... establish a comprehensive relationship in the areas of ...
(Date:9/22/2014)... 22, 2014 Research reveals that the ... , significantly declines during the aging process. This decline ... tear, such as wrinkles, droopy skin, weakened muscles and ... of Pulsatile Growth Hormone (GH) Secretion and Insulin-Like Growth ... thus, triggering the aging process. , Decades of ...
(Date:9/22/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief executive officer search ... The top executive search firm in the healthcare industry, ... healthcare executives into organizations. , An 18-bed, acute ... Benson and the surrounding communities. The hospital has delivered ...
(Date:9/22/2014)... Purchasing greenhouse starter kits or related ... positive outcome. Gothic Arch Greenhouses has ... leader in the industry and a valued source for ... owner of Gothic Arch Greenhouses, it’s important to first ... controlled air created inside a greenhouse makes it desirable ...
Breaking Medicine News(10 mins):Health News:Coffee Drinkers Are Charged More For Life Insurance, Reports LifeAnt.com 2Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 2Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 3Health News:Diet Doc Reveals the Secret to Looking and Feeling Younger with new Prescription Sermorelin hGH Anti-Aging Therapy 2Health News:Diet Doc Reveals the Secret to Looking and Feeling Younger with new Prescription Sermorelin hGH Anti-Aging Therapy 3Health News:Swift County-Benson Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Swift County-Benson Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Gothic Arch Greenhouses provides the Answers to the Many Questions and Considerations of Greenhouse Ownership 2Health News:Gothic Arch Greenhouses provides the Answers to the Many Questions and Considerations of Greenhouse Ownership 3
... Reporter , TUESDAY, Aug. 10 (HealthDay News) -- Another ... women finds that the panorama of risks is even ... showed a higher risk of developing breast cancer than ... the longer a woman used either estrogen-alone therapy or ...
... TUESDAY, Aug. 10 (HealthDay News) -- Almost one in three ... diabetic retinopathy, according to new research. What,s more, ... that,s so advanced it,s threatening their vision, reports the study ... of the American Medical Association . "This was a ...
... Cancer Prevention Trial (PCPT), which showed a significant reduction in ... its use, according to a study published in the September ... journal of the American Association for Cancer Research. ... in The New England Journal of Medicine and ...
... the use of oral bisphosphonates (drugs that prevent the loss ... from more than 80,000 patients in the United Kingdom found ... new cases of esophageal or gastric cancer, according to a ... Bisphosphonates are mainly used to prevent or treat ...
... department patients with shortness of breath and a risk ... a stethoscope. It allows them to hear the ... strongly associated with cardiac disease and heart failure. However, ... hear with a stethoscope alone. In a study ...
... look at simplified English-language consent forms translated into another ... translated consent form meets readability standards. The study appears ... . Nearly half of all U.S.-based clinical trials ... native language is not English and whose population has ...
Cached Medicine News:Health News:Weight a Factor in Breast Cancer Risk After HRT Use 2Health News:Weight a Factor in Breast Cancer Risk After HRT Use 3Health News:Eye Disease Affects Nearly One in Three Diabetics 2Health News:Eye Disease Affects Nearly One in Three Diabetics 3Health News:Study shows physicians reluctant to use chemoprevention for prostate cancer 2Health News:Study shows physicians reluctant to use chemoprevention for prostate cancer 3Health News:Drugs used to treat osteoporosis not linked with higher risk of esophageal cancer 2Health News:Heart's sounds can help diagnose heart failure 2
(Date:9/19/2014)... Sept. 19, 2014 /PRNewswire-iReach/ -- Market Research ... Industry, 2009-2019 is a professional and in-depth ... Hydrochloride industry. The report firstly reviews the ... classification, application and manufacturing technology. The report ... of Oxybutynin Hydrochloride listing their product specification, ...
(Date:9/19/2014)... , Sept. 19, 2014  The board of directors ... a quarterly cash dividend of $0.42 per share.  ... 2014 to stockholders of record at the close of ... AbbVie is a global, research-based biopharmaceutical company formed in ... to use its expertise, dedicated people and unique approach ...
(Date:9/19/2014)... Sept. 19, 2014 Merck (NYSE: MRK ), ... and Canada , is teaming with celebrity chef ... Logra Tus Metas , an educational program encouraging Hispanics with type ... a key treatment goal to help reduce the risk of serious ... are at a higher risk for developing type 2 diabetes than ...
Breaking Medicine Technology:Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... 3, 2011 As 73% of all registered hospitals ... or less, collectively these hospitals account for the largest ... to emergency and medical care, the role of community ... sustain community healthcare with quality physicians and equipment, community ...
... 2011 Ventus Medical is pleased to announce ... innovative, non-invasive treatment for obstructive sleep apnea (OSA), ... BMedical Pty. Ltd. will be the strategic distribution ... (Photo:   http://photos.prnewswire.com/prnh/20110209/SF45785-a ) ...
Cached Medicine Technology:Craneware Supports Forward-Thinking Community Hospital Executives to Strengthen U.S. Community Healthcare's Business Performance 2Craneware Supports Forward-Thinking Community Hospital Executives to Strengthen U.S. Community Healthcare's Business Performance 3Ventus Medical Launches Provent® Sleep Apnea Therapy in Australia and New Zealand 2Ventus Medical Launches Provent® Sleep Apnea Therapy in Australia and New Zealand 3
... PDSHEART provides all equipment, supplies, and all patient ... hookup for setting the patient up in your ... patient), and the professional component, for interpreting the ... service provider to offer full access to your ...
... Cardiac Services is a leading provider ... people, combined with state-of-the-art technology deliver ... that supports healthcare professionals and clients ... uses telecommunications and ECG technology to ...
... microplate incubator is an extremely compact ... single microplate up to 50C. ... requiring higher temperatures up to 65C. ... low cost and high performance for ...
... Incubator/Shaker HT is designed for ... Incubator/Shaker HT is ideal for ... and primer extension assays. iEMS ... a one-cabinet model, allowing the ...
Medicine Products: